
Sign up to save your podcasts
Or


STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.
By STAT4.5
320320 ratings
STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.

1,993 Listeners

756 Listeners

1,105 Listeners

818 Listeners

498 Listeners

125 Listeners

6,097 Listeners

61 Listeners

85 Listeners

34 Listeners

5,576 Listeners

55 Listeners

21 Listeners

403 Listeners

17 Listeners

11 Listeners